Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials.

Grill JD, Karlawish J.

Alzheimers Res Ther. 2010 Dec 21;2(6):34. doi: 10.1186/alzrt58.

2.

Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.

Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A, Grant A; STEPS group.

Health Technol Assess. 2007 Nov;11(48):iii, ix-105. Review.

3.

Challenging recruitment of youth with type 2 diabetes into clinical trials.

Nguyen TT, Jayadeva V, Cizza G, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI.

J Adolesc Health. 2014 Mar;54(3):247-54. doi: 10.1016/j.jadohealth.2013.08.017. Epub 2013 Oct 23. Review.

4.

WITHDRAWN: Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000202. Review.

PMID:
17636619
5.

Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, López-Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2000;(2):CD000202. Review. Update in: Cochrane Database Syst Rev. 2000;(3):CD000202.

PMID:
10796507
6.

New and emerging treatments for Alzheimer's disease.

Corbett A, Ballard C.

Expert Opin Emerg Drugs. 2012 Jun;17(2):147-56. doi: 10.1517/14728214.2012.675327. Epub 2012 Mar 23. Review.

PMID:
22439621
7.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

8.

Rivastigmine for Alzheimer's disease.

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3. Review.

PMID:
25858345
9.

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.

PMID:
12535396
10.

Involving South Asian patients in clinical trials.

Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P.

Health Technol Assess. 2004 Oct;8(42):iii, 1-109. Review.

11.

Current challenges for the successful treatment and prevention of Alzheimer's disease: treating the pathologies of the disease to change its clinical course.

Schenk D.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S119-21. doi: 10.1016/j.jalz.2007.11.009. Epub 2007 Dec 21. Review.

PMID:
18631987
12.

Nimodipine for primary degenerative, mixed and vascular dementia.

López-Arrieta JM, Birks J.

Cochrane Database Syst Rev. 2002;(3):CD000147. Review.

PMID:
12137606
13.

Rivastigmine for Alzheimer's disease.

Birks J, Iakovidou V, Tsolaki M.

Cochrane Database Syst Rev. 2000;(2):CD001191. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001191.

PMID:
10796621
14.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
15.

Rivastigmine for Alzheimer's disease.

Birks JS, Chong LY, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Sep 22;9:CD001191. [Epub ahead of print] Review.

PMID:
26393402
16.

Pharmacotherapies for sleep disturbances in Alzheimer's disease.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178.

PMID:
24659320
17.

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Health Technol Assess. 2001;5(1):1-137. Review.

18.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(1):CD001747. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001747.

PMID:
11279727
19.

A new model for developing and executing culturally appropriate behavior modification clinical trials for African Americans.

Ard JD, Carter-Edwards L, Svetkey LP.

Ethn Dis. 2003 Spring;13(2):279-85. Review.

PMID:
12785426
20.

Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2000;(3):CD000202. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD000202.

PMID:
10908463

Supplemental Content

Support Center